ESTRELLA IMMUNOPHARMA, INC. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ESTRELLA IMMUNOPHARMA, INC. payments for repurchase of equity for the quarter ending 2025-12-31 was $0.00.
- ESTRELLA IMMUNOPHARMA, INC. payments for repurchase of equity for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. payments for repurchase of equity for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. payments for repurchase of equity for the quarter ending 2025-03-31 was $29.46K, a 64.96% decline year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. payments for repurchase of equity for fiscal 2025 was $29.46K.
- ESTRELLA IMMUNOPHARMA, INC. payments for repurchase of equity for fiscal 2024 was $354.44K.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $29.46K 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | |
| 2025-03-31 | $29.46K 10-Q · filed 2026-05-18 | |
| 2024-09-30 | $150.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2024-06-30 | $270.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $354.44K 10-KT · filed 2025-03-25 |
| 2024-03-31 | $84.09K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |